{"text": "Obesity is a growing concern worldwide, affecting approximately 39% of\n\nadults in the United States (CDC). The impact of weight on antipsychotic\n\npharmacokinetics and efficacy has been an area of interest for researchers.\n\nThis section will explore the effects of weight on antipsychotics, focusing on\n\npharmacokinetics and efficacy in obese patients.\n\nWeight-Related Changes in Antipsychotic Pharmacokinetics\n\nStudies have shown that obesity can affect the pharmacokinetics of", "embedding": []}